Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 12 of 23 for:    BGB-3111

Study of BTK Inhibitor BGB-3111 in Subjects With Relapsed/Refractory Non-GCB Type Diffuse Large B Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03145064
Recruitment Status : Active, not recruiting
First Posted : May 9, 2017
Last Update Posted : May 20, 2019
Sponsor:
Information provided by (Responsible Party):
BeiGene

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : May 24, 2019
Estimated Study Completion Date : August 24, 2019